A potential method for in vivo range verification in proton therapy treatment

Proton therapy potentially offers excellent dose conformality and reduction in integral dose. The superior dose distribution is, however, much more sensitive to the radiological depth along the beam path than for photon fields. Variations in this depth due to inaccurate planning calculation, setup uncertainty, respiration-induced organ motion, etc, could result in either an 'undershooting', missing the distal portion of the target volume entirely, or an 'overshooting', delivering the full prescription dose to the normal tissue beyond the target volume. In vivo dose verification plays an important role in the quality assurance of the treatments. The point dose measurements widely used for photon treatments are, however, insufficient for protons due to the particular characteristics of the proton depth-dose distribution. In this work, we explore a method for in vivo range verifications in proton treatments using range-modulated passive scattering fields. The method utilizes the time dependence of the dose distribution delivered by these fields. By measuring the time dependence of the dose rate at any point in the target volume, the residual range of the beam at this point can be obtained with millimeter accuracy.

[1]  Stanley J. Rosenthal,et al.  Intra- and interfractional patient motion for a variety of immobilization devices. , 2005, Medical physics.

[2]  Katia Parodi,et al.  Charged hadron tumour therapy monitoring by means of PET , 2004 .

[3]  Robert J. Schneider,et al.  Range modulators for protons and heavy ions , 1975 .

[4]  Roelf Slopsema,et al.  Sensitivities in the production of spread-out Bragg peak dose distributions by passive scattering with beam current modulation. , 2007, Medical physics.

[5]  Shinichi Minohara,et al.  Estimating uncertainties of the geometrical range of particle radiotherapy during respiration. , 2003, International journal of radiation oncology, biology, physics.

[6]  Hanne M Kooy,et al.  Target volume dose considerations in proton beam treatment planning for lung tumors. , 2005, Medical physics.

[7]  Katia Parodi,et al.  Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. , 2007, International journal of radiation oncology, biology, physics.

[8]  Hsiao-Ming Lu,et al.  Optimization of current modulation function for proton spread-out Bragg peak fields. , 2006, Medical physics.

[9]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[10]  H Paganetti,et al.  Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. , 2004, Medical physics.

[11]  Benjamin E Nelms,et al.  An analysis of an implantable dosimeter system for external beam therapy. , 2005, International journal of radiation oncology, biology, physics.

[12]  E Pedroni,et al.  Proton radiography as a tool for quality control in proton therapy. , 1995, Medical physics.

[13]  Steve B Jiang,et al.  A respiratory-gated treatment system for proton therapy. , 2007 .

[14]  B J Mijnheer,et al.  In vivo dosimetry during external photon beam radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[15]  E Pedroni,et al.  The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power. , 1998, Physics in medicine and biology.

[16]  S Minohara,et al.  Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.